Latest1 information on COVID-19
©2022 Stanford Medicine
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Not Recruiting
Trial ID: NCT01351545
Purpose
This study is an access and distribution protocol for unlicensed cryopreserved cord blood
units (CBUs) in pediatric and adult patients with hematologic malignancies and other
indications.
Official Title
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients With Hematologic Malignancies and Other Indications
Stanford Investigator(s)
Andrew Rezvani, M.D.
Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Eligibility
Inclusion Criteria:
- Disorders affecting the hematopoietic system that are inherited, acquired, or result
from myeloablative treatment
- Signed informed consent (and signed assent, if applicable) obtained prior to study
enrollment
- Pediatric and adult patients of any age
Exclusion Criteria:
- Patients who are receiving only licensed CBUs
- Cord blood transplant recipients at international transplant centers
- Patients who are enrolled on another IND protocol to access the unlicensed CBU(s)
- Patients whose selected unlicensed CBU(s) will be more than minimally manipulated
Intervention(s):
drug: A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs)
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Sandhya Kharbanda, MD